3 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 3 of 3 clinical reviews.
Evidence-based review of sildenafil safety differences in Black and African ancestry patients, covering pharmacogenomics, cardiovascular risk, G6PD, dosing, and drug interactions.
East Asian patients may need lower sildenafil starting doses due to CYP2C19 poor-metabolizer prevalence, lower average BMI, and distinct pharmacokinetic profiles. Evidence-based dosing guidance from PharmGKB, RCT subgroup data, and population PK studies.
A deep dive into how sildenafil (Viagra) performs differently in Black and African ancestry patients, covering pharmacogenomics, hypertension interactions, G6PD prevalence, CKD risk, and evidence-based dosing strategies.